Adenosine receptors as emerging therapeutic targets for diabetic kidney disease.

Pak, Eun Seon; Cha, Jin Joo; Cha, Dae Ryong; Kanasaki, Keizo; Ha, Hunjoo

Pak, Eun Seon; Cha, Jin Joo; Cha, Dae Ryong; Kanasaki, Keizo; Ha, Hunjoo.

Afiliação

Pak ES; Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea.
Cha JJ; Department of Nephrology, Korea University Ansan Hospital, Ansan, Republic of Korea.
Cha DR; Department of Nephrology, Korea University Ansan Hospital, Ansan, Republic of Korea.
Kanasaki K; Department of Internal Medical 1, Shimane University Faculty of Medicine, Izumo, Japan.
Ha H; Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea.

Kidney Res Clin Pract ; 41(Suppl 2): S74-S88, 2022 Sep.

Article em En | MEDLINE | ID: mdl-36239063

Palavras-chave

Adenosine; Diabetic kidney disease; Fibrosis; Purinergic P1 receptor agonists; Purinergic P1 receptor antagonists; Purinergic P1 receptors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article